![]() |
| Liver Cirrhosis |
|
Free Subscription
1 Dig Dis Sci |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Association Between High FIB-4 Score and the Risk of Malignancy Development and
Mortality: A Retrospective Longitudinal Case-Control Study.
Dig Dis Sci. 2025;70:3525-3537.
PubMed
Abstract available
Time to focus on POCUS For AKI management in cirrhosis.
Hepatology. 2025 Oct 16. doi: 10.1097/HEP.0000000000001583.
PubMed
Global burden of HBV-related liver disease: Primary liver cancer due to chronic
HBV infection increased in over one-third of countries globally from 2000 to
2021.
Hepatology. 2025;82:1274-1286.
PubMed
Abstract available
Identification of optimal portal pressure decrease to control ascites while
minimizing hepatic encephalopathy after TIPS: A multicenter study.
Hepatology. 2025 Jan 3. doi: 10.1097/HEP.0000000000001219.
PubMed
Abstract available
Prevalence of metabolic dysfunction-associated steatotic liver disease and
fibrosis defined by liver elastography in the United States using National Health
and Nutrition Examination Survey 2017-March 2020 and August 2021-August 2023
data.
Hepatology. 2025;82:1256-1273.
PubMed
Abstract available
MASH clinical trials and drugs pipeline: An impending tsunami.
Hepatology. 2025;82:1325-1340.
PubMed
Abstract available
Validation of novel scoring systems for acute decompensated cirrhosis identifies
PBC as an independent poor prognostic factor: a single-center Japanese cohort
study.
J Gastroenterol. 2025 Oct 12. doi: 10.1007/s00535-025-02310.
PubMed
Abstract available
Celiac Disease and Its Impact on Liver-Related Outcomes in Patients With
All-Cause Cirrhosis: The CELIHEP Study.
J Gastroenterol Hepatol. 2025 Oct 16. doi: 10.1111/jgh.70082.
PubMed
Abstract available
Comment on Impact of Renin-Angiotensin-Aldosterone System Inhibitors on
Liver-Related Events and Mortality in Patients With Cirrhosis: A Meta-Analysis of
Real-World Evidence.
J Gastroenterol Hepatol. 2025 Oct 16. doi: 10.1111/jgh.70114.
PubMed
Early portopulmonary hypertension predicts mortality in patients with cirrhosis:
insights from the PORTO-DETECT cohort.
J Hepatol. 2025 Oct 9:S0168-8278(25)02490-0. doi: 10.1016/j.jhep.2025.
PubMed
Abstract available
Primary prophylaxis of spontaneous bacterial peritonitis using rifaximin in
patients with severe cirrhosis and ascites, not the end of the story?
J Hepatol. 2025 Oct 9:S0168-8278(25)02551-6. doi: 10.1016/j.jhep.2025.
PubMed
Reply to: RIPK3 in acutely decompensated cirrhosis: prognostic promise and
analytic pitfalls.
J Hepatol. 2025 Oct 9:S0168-8278(25)02549-8. doi: 10.1016/j.jhep.2025.
PubMed
The association of race with time to severe liver disease diagnoses.
PLoS One. 2025;20:e0334016.
PubMed
Abstract available
The prognostic value of the direct bilirubin to albumin ratio in critically ill
patients with cirrhosis: Insights from MIMIC-IV database.
PLoS One. 2025;20:e0334591.
PubMed
Abstract available
Thank you for your interest in scientific medicine.